GlassScriptPhysician profile
Aaron Farrow
NPI 1376864439
$172,160.73
in general payments reported to CMS, 2019-2025
80 companies · $47K in 2025
The $47K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $16K · 2021: $17K · 2022: $24K · 2023: $15K · 2024: $29K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $73K · Food and Beverage: $14K · Consulting Fee: $2,462 · Travel and Lodging: $1,139 · Education: $71.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,844.00 |
| Food and Beverage | $14,353.16 |
| Consulting Fee | $2,462.00 |
| Travel and Lodging | $1,139.40 |
| Education | $71.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $116,566.44 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Abbvie INC. | $30,546.48 | 2021-2025 | |
| Ucb, INC. | $1,965.85 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Novartis Pharmaceuticals Corporation | $1,550.63 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,322.09 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Lundbeck LLC | $1,222.06 | 2019-2025 | Vyepti, Rexulti |
| Allergan, INC. | $1,032.80 | 2019-2022 | |
| Amgen INC. | $1,030.48 | 2019-2025 | Uplizna, Aimovig |
| Acadia Pharmaceuticals INC | $968.14 | 2020-2025 | Nuplazid, Daybue |
| Alexion Pharmaceuticals, INC. | $915.76 | 2019-2025 | Ultomiris |
| Supernus Pharmaceuticals, INC. | $845.53 | 2019-2022 | |
| Genentech USA, INC. | $838.49 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Genzyme Corporation | $831.63 | 2019-2023 | |
| Sk Life Science, INC. | $823.67 | 2020-2025 | Xcopri |
| Merz Pharmaceuticals, LLC | $803.89 | 2021-2025 | Xeomin, Inbrija |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $797.37 | 2020-2025 | |
| Eisai INC. | $528.45 | 2020-2025 | |
| Impel Pharmaceuticals INC. | $505.42 | 2022-2023 | Trudhesa |
| Tg Therapeutics, INC. | $495.23 | 2023-2025 | |
| Lilly USA, LLC | $457.13 | 2019-2025 | Emgality, Reyvow, Kisunla |
| Alnylam Pharmaceuticals INC. | $423.86 | 2019-2024 | Onpattro |
| Amneal Pharmaceuticals LLC | $410.85 | 2019-2025 | Rytary, Ongentys, Crexont |
| Sunovion Pharmaceuticals INC. | $401.42 | 2019-2022 | |
| Livanova USA, INC. | $399.85 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceuticals, INC. | $350.46 | 2021 | |
| Upsher-Smith Laboratories LLC | $348.03 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $344.85 | 2021-2025 | Ingrezza, Ongentys |
| Csl Behring | $342.27 | 2020-2025 | Hizentra |
| Biohaven Pharmaceutical Holding Company LTD. | $337.43 | 2022 | |
| Celgene Corporation | $324.91 | 2020-2025 | Zeposia |
| Janssen Pharmaceuticals, INC | $309.72 | 2020-2023 | Ponvory |
| Emd Serono, INC. | $292.64 | 2019-2023 | Mavenclad |
| Kyowa Kirin, INC. | $273.15 | 2020-2024 | Nourianz |
| Argenx US, INC. | $271.83 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| E.R. Squibb & Sons, L.L.C. | $264.63 | 2020-2022 | |
| Mdd US Operations, LLC | $255.34 | 2019-2020 | |
| Grifols USA, LLC | $216.72 | 2019-2025 | Gamunex-C |
| Ge Healthcare | $188.79 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $179.44 | 2023-2024 | Aptiom |
| Acorda Therapeutics, INC | $168.93 | 2019-2023 | Ampyra, Inbrija |
| Vanda Pharmaceuticals INC. | $167.87 | 2024-2025 | Ponvory |
| Adamas Pharmaceuticals, INC. | $129.37 | 2019-2021 | |
| Horizon Therapeutics Plc | $122.57 | 2022 | |
| Jazz Pharmaceuticals INC. | $101.12 | 2021-2025 | |
| Mallinckrodt Enterprises LLC | $98.23 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $84.58 | 2022-2025 | Dysport |
| Catalyst Pharmaceuticals, INC. | $83.20 | 2023-2025 | Fycompa |
| Arbor Pharmaceuticals, INC. | $82.58 | 2019-2022 | |
| Avion Pharmaceuticals | $81.51 | 2022 | |
| Corium, LLC | $81.51 | 2022-2023 | Adlarity |
| Azurity Pharmaceuticals, INC. | $66.64 | 2023-2025 | Horizant, Horizant |
| Tanabe Pharma America, INC. | $62.03 | 2019-2022 | |
| Medtronic, INC. | $61.66 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Greenwich Biosciences, INC. | $61.11 | 2019 | |
| Ani Pharmaceuticals, INC. | $56.82 | 2022-2023 | Purified Cortrophin Gel |
| Impel Pharmaceuticals LLC | $54.30 | 2025 | Trudhesa |
| Grt US Holding, INC. | $42.72 | 2022 | |
| Vertical Pharmaceuticals, LLC | $41.40 | 2019 | |
| Strongbridge US INC. | $39.62 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $39.58 | 2021-2022 | |
| Octapharma USA, INC. | $39.37 | 2023 | Panzyga, Octagam Immune Globulin (Human) |
| Scilex Pharmaceuticals INC. | $36.56 | 2023 | Ztlido |
| Astrazeneca Pharmaceuticals LP | $33.45 | 2025 | Wainua |
| Promius Pharma LLC | $33.42 | 2019 | |
| Mallinckrodt Hospital Products INC. | $30.63 | 2020 | |
| Avanir Pharmaceuticals, INC. | $29.38 | 2019-2022 | |
| Zogenix INC. | $27.30 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.92 | 2023 | Rexulti |
| Banner Life Sciences, LLC | $23.34 | 2023 | |
| Sandoz INC. | $23.12 | 2023 | |
| Dynasplint Systems INC. | $20.27 | 2025 | Dynasplint |
| Endo Pharmaceuticals INC. | $18.63 | 2020 | |
| Neurelis, INC. | $16.94 | 2023 | Valtoco |
| Tonix Medicines, INC. | $14.22 | 2025 | Zembrace Symtouch |
| Takeda Pharmaceuticals U.S.A., INC. | $13.57 | 2024 | Hyqvia |
| Collegium Pharmaceutical, INC. | $13.52 | 2022 | |
| Almatica Pharma LLC | $13.02 | 2021 | |
| Currax Pharmaceuticals LLC | $12.89 | 2023 | Onzetra Xsail |
| Zyla Life Sciences, INC. | $12.62 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Farrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.